Free Trial
NYSE:HQH

Abrdn Healthcare Investors (HQH) Stock Price, News & Analysis

Abrdn Healthcare Investors logo
$18.03
-0.13 (-0.72%)
(As of 10/31/2024 ET)

About Abrdn Healthcare Investors Stock (NYSE:HQH)

Key Stats

Today's Range
$17.99
$18.16
50-Day Range
$18.16
$19.27
52-Week Range
$14.47
$19.79
Volume
111,267 shs
Average Volume
156,334 shs
Market Capitalization
$912.77 million
P/E Ratio
N/A
Dividend Yield
11.31%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Receive HQH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abrdn Healthcare Investors and its competitors with MarketBeat's FREE daily newsletter.

HQH Stock News Headlines

The real reason Elon is fully endorsing Trump
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.
Bill Maher's Net Worth
See More Headlines

HQH Stock Analysis - Frequently Asked Questions

Abrdn Healthcare Investors' stock was trading at $16.57 on January 1st, 2024. Since then, HQH shares have increased by 8.8% and is now trading at $18.03.
View the best growth stocks for 2024 here
.

Abrdn Healthcare Investors' top institutional shareholders include Raymond James & Associates (0.70%), Janney Montgomery Scott LLC (0.31%), Private Advisor Group LLC (0.08%) and International Assets Investment Management LLC (0.07%). Insiders that own company stock include Daniel R Omstead, Todd Reit and Rose Dimartino.
View institutional ownership trends
.

Shares of HQH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abrdn Healthcare Investors investors own include Enterprise Products Partners (EPD), Medical Properties Trust (MPW), Energy Transfer (ET), Mplx (MPLX), PIMCO Dynamic Income Fund (PDI), Cohen & Steers Infrastructure Fund (UTF) and Cleveland-Cliffs (CLF).

Company Calendar

Ex-Dividend for 9/30 Dividend
8/23/2024
Dividend Payable
9/30/2024
Today
10/31/2024
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Sector
Finance
Industry
Investment offices, not elsewhere classified
Sub-Industry
Financial Services
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$74.55 million

Miscellaneous

Free Float
46,929,000
Market Cap
$916.82 million
Optionable
Not Optionable
Beta
0.76
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:HQH) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners